Results 121 to 130 of about 28,144 (206)

Clinical characteristics of apixaban prescription in AF patients with single dose-reduction criterion: the ASPIRE (efficAcy and safety of aPixaban in rEal-world practice in Korean frail patients with atrial fibrillation) study

Frontiers in Cardiovascular Medicine
BackgroundData on off-label reduced dose risk among patients with atrial fibrillation (AF) who qualify for a single-dose reduction of apixaban is scarce.ObjectivesWe prospectively assessed apixaban dosing and clinical characteristics in AF patients ...
JungMin Choi, So-Ryoung Lee, So-Ryoung Lee, Soonil Kwon, Hyo-Jeong Ahn, Kyung-Yeon Lee, Jong-Sung Park, Jong-Il Choi, Sung Ho Lee, Jung Ho Heo, Il-Young Oh, Young Keun On, Hee Tae Yu, Kwang-No Lee, Nam-Ho Kim, Hyung Wook Park, Hyung Wook Park, Ki Hong Lee, Ki Hong Lee, Seung Yong Shin, Seil Oh, Seil Oh, Gregory Y. H. Lip, Gregory Y. H. Lip, Gregory Y. H. Lip, Seongwook Han, Eue-Keun Choi, Eue-Keun Choi   +27 more
doaj   +1 more source

Überzeugendes Nutzen-Risiko-Profil mit Apixaban

, 2018
Apixaban (Eliquis®) ist seit 2014 zur Behandlung von tiefen Venenthrombosen (TVT) und Lungenembolien (LE) sowie zur Prophylaxe rezidivierender TVT und LE bei Erwachsenen zugelassen (1).
Beate Grübler
core   +1 more source

Apixaban versus warfarin in nephrotic syndrome: thromboembolic events, bleeding risk and changes in profibrotic and inflammatory cytokines

Український Журнал Нефрології та Діалізу
Nephrotic syndrome (NS) is associated with a high risk of thromboembolic complications and activation of inflammatory and profibrotic pathways. The optimal anticoagulation strategy in NS remains uncertain. Objective.
I. Mykhaloiko, R. Yatsyshyn
doaj   +1 more source

Apixaban versus enoxaparin to prevent venous thromboembolism in post-operative patients with gynecologic cancers at an urban academic medical center

Gynecologic Oncology Reports
Objective: A recent clinical trial demonstrated that the use of apixaban was safe and equal to enoxaparin (LMWH) in post-operative gynecologic oncology patients.
Victoria Diamond, Katherine Gerber, Geno Merli, Rebecca Mercier, Aaron Shafer, Norman Rosenblum   +5 more
doaj   +1 more source

Apixaban plasma concentrations before and after catheter ablation for atrial fibrillation.

PLoS ONE
BackgroundCatheter ablation in patients with atrial fibrillation is associated with a transient increase in thromboembolic risk and adequate anticoagulation is highly important.
Rachel Aakerøy, Jan Pål Loennechen, Roar Dyrkorn, Stian Lydersen, Arne Helland, Olav Spigset   +5 more
doaj   +1 more source

Clinical utility of apixaban in the prevention and treatment of venous thromboembolism: current evidence

Drug Design, Development and Therapy, 2014
Ali Zalpour,1 Thein Hlaing Oo21Division of Pharmacy – Clinical Programs, 2Section of Thrombosis and Benign Hematology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAAbstract: Anticoagulation with heparin and vitamin K ...
Zalpour A, Oo TH
doaj  

Apixaban in Abdominal Transplantation: An Antithrombotic Stewardship Assessment. [PDF]

Adv Hematol
Kwiatkowski D, Ahuja T, Patolia R, Pluckrose DM, Green D, Jonchhe S.   +5 more
europepmc   +1 more source

<i>In vitro</i> comparison of the effects of abelacimab, dalteparin, and apixaban on catheter-induced clotting and thrombin generation. [PDF]

Res Pract Thromb Haemost
Yin R, Guo X, Fredenburgh JC, Weitz JI.
europepmc   +1 more source

The use of direct oral anticoagulants in children with congenital and acquired heart disease. [PDF]

Front Cardiovasc Med
Abdelghani E, Thakkar M, Berthiaume J, Ahuja S.   +3 more
europepmc   +1 more source

Direct Oral Anticoagulants Versus Vitamin K Antagonists for Treatment of Left Ventricular Thrombus: A Review of Efficacy and Safety. [PDF]

Rev Cardiovasc Med
Alqawasmi M, Alrahamneh O, Jawadi A, Blankenship JC.   +3 more
europepmc   +1 more source